tiprankstipranks

Sumant Kulkarni Profile - Canaccord Genuity Analyst

473 Followers
tipranks
Sumant Kulkarni

Sumant Kulkarni
Canaccord Genuity

Wall Street Analyst
#1,448 out of 12,290 Wall Street Analysts
#3,321 out of 28,763 experts

Success Rate

46%
227 out of 496 ratings made a profit

Average Return

+8.70%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Sumant Kulkarni's trades since 2015 and holding each position for 1 Year would result in 45.77% of your transactions generating a profit, with an average return of 8.7% per rating.

Stock Rating Distribution

690Ratings
90.87% Buy
7.68% Hold
1.45% Sell
Distribution of Sumant Kulkarni's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United States
Canada

Best Rating

Stock:
Bioxcel Therapeutics
(BTAI)
Rating:Buy
Date:Oct 04, 2019 - Oct 04, 2020
Return:+614.20%
The most profitable rating made by Sumant Kulkarni

Sumant Kulkarni's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Bausch Health Companies
Dec 18, 2015
Buy
Reiterated
C$194.58
(2567.29% Upside)
7Ratings
0.00%
Perrigo Company
Jun 14, 2016
Sell
Reiterated
$109.00
(928.30% Upside)
2Ratings
100%
+31.95%
Amneal Pharmaceuticals
Nov 07, 2016
Sell
Reiterated
$19.00
(39.71% Upside)
4Ratings
100%
+1.40%
Viatris
Nov 09, 2016
Buy
Reiterated
$53.00
(232.91% Upside)
8Ratings
0%
-10.83%
Teva Pharmaceutical
Jan 31, 2017
Buy
Upgraded
9Ratings
0%
-22.78%
vTv Therapeutics
Apr 09, 2018
Hold
Reiterated
4Ratings
0%
-24.10%
Quince Therapeutics
Jan 28, 2022
Hold
Downgraded
$12.00
(985.97% Upside)
12Ratings
20%
-34.83%
Tvardi Therapeutics
Jun 12, 2024
Hold
Downgraded
$36.00
(1059.42% Upside)
10Ratings
11%
-44.96%
Bioxcel Therapeutics
Sep 05, 2025
Buy
Reiterated
$18.00
(1351.61% Upside)
55Ratings
29%
+28.26%
Helus Pharma
Mar 06, 2026
Buy
Reiterated
$45.00
(929.75% Upside)
22Ratings
0%
-39.59%
List of latest recommendations made by Sumant Kulkarni. Click to expand and see Sumant Kulkarni's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Advertisement
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

About Analyst Ratings

About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•  
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•  
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•  
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.

Sumant Kulkarni activity FAQ

What is the performance of Sumant Kulkarni's recommendations?
The percentage of profitable recommendations made by Sumant Kulkarni is 46%, and the average return per transaction is 8.70%.
    What stocks does Sumant Kulkarni cover?
    Sumant Kulkarni mostly covers BIIB ,BTAI ,ACAD stocks.
      What was Sumant Kulkarni's most profitable rating?
      Sumant Kulkarni’s most profitable ratings was a buy on BTAI stock on Oct 04, 2019 - Oct 04, 2020. The return on the trade was +614.20%.
        Where can I see a list of stock analyst ratings?
        You can see a list of daily stock analyst ratings here.
          What are the most recommended stocks by analysts?
          You can see a list of the most recommended stocks by analysts here